HighPost Capital

HighPost Capital is a private equity firm that invests and focuses on the global consumer and consumer technology sectors. It seeks to leverage its principals' respective skills, networks, and experience to create long-term value for its portfolio companies. HighPost seeks to identify opportunities with family-controlled and entrepreneur-led companies that share a differentiated approach to value creation.

David S. Moross

Co-Founder, Chairman and CEO

2 past transactions

Magic Spoon

Series B in 2022
Magic Spoon is a food company that provides childlike, low-carbohydrate cereal foods for adult customers. The cereal is keto-friendly and non-GMO and free from gluten, grain, wheat, soy, and artificial sweeteners. It gets its taste from allulose, a natural sweetener found in figs and maple syrup that has zero glycemic impact. The company was established in 2019 and has its main office in Brooklyn, New York.

Spotter

Series D in 2022
Spotter is a platform for Creators, providing services and software designed to accelerate growth for the world’s best Creators and brands. Creators working with Spotter can access the capital, knowledge, community, and personalized AI software products they need to succeed. With unique knowledge of how Creators work, the resources they need to grow, and the challenges they face, Spotter is empowering top YouTube Creators to succeed. Spotter has already deployed over $940 million to YouTube Creators to reinvest in themselves and accelerate their growth, with plans to reach $1 billion in investment by 2024. With a premium catalog that spans over 725,000 videos, Spotter generates more than 88 billion monthly watch-time minutes, delivering a unique scaled media solution to Advertisers and Ad Agencies that is transparent, efficient, and 100% brand safe. For more information about Spotter, please visit https://spotter.com.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.